Costs of Care and Cost-Effectiveness Analysis
Year: 2003
Type: book-chapter
Abstract: Since the 1990s, advances in intraoperative myocardial protection and postoperative care, as well as other surgical and anesthetic techniques, have extended the range of patients who may be offered valvular surgery. With these improvements in the medical and surgical care of the cardiac patient, the benefits of surgery have been extended to patients who were previously deemed inoperable because of their high-risk status. The increasing interest in cost-effectiveness analysis (CEA) of heart valve surgical procedures is not surprising, as the constraints on health care spending becomes tighter, and competition among providers and managed care organizations becomes more intense. These analyses are further complicated by the costly market-driven technological advances in heart surgery. Currently, there is no large randomized trial assessing the cost-effectiveness (CE) of heart valve surgery in terms of cost per event prevented, cost per life year saved, and cost of quality-adjusted life year (QALY) saved. Therefore, the majority of data published thus far includes inferred in-hospital valve surgery cost, without delineation of CE.
Source: Humana Press eBooks
Authors: Vinod H. Thourani, William S. Weintraub
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2188626988